National Academies Press: OpenBook

Responsible Science: Ensuring the Integrity of the Research Process: Volume II (1993)

Chapter: Part C: Specific Research Policies and Practices

« Previous: 11 Report of the Committee on Academic Responsibility
Suggested Citation:"Part C: Specific Research Policies and Practices." National Academy of Sciences, National Academy of Engineering, and Institute of Medicine. 1993. Responsible Science: Ensuring the Integrity of the Research Process: Volume II. Washington, DC: The National Academies Press. doi: 10.17226/2091.
×

14
PHS Policy Relating to Distribution of Unique Research Resources Produced with PHS Funding

National Institutes of Health

Investigators conducting biomedical research frequently develop unique research resources. Categories of these resources include organisms, cells, viruses, cell products, cloned DNA, as well as DNA sequences, mapping information, and crystallographic coordinates. Some specific examples are specialized and/or genetically defined cells, including normal and diseased human cells; monoclonal cell lines; hybridoma cell lines; microbial cells and products; viruses and viral products; recombinant nucleic acid molecules; DNA probes; nucleic acid and protein sequences; and transgenic mice. The Public Health Service (PHS) provides the following statement of policy concerning unique research resources developed through its awards.

A. PHS Policy on Distribution of Research Resources

It is the policy of the PHS to make available to the public the results and accomplishments of the activities that it funds. Restricted availability of unique resources upon which further studies are dependent can impede the advancement of research and the delivery of medical care. Therefore, when these resources are developed with PHS funds and the associated research findings have been published or after they have been provided to NIH under contract, they should be made readily available for research purposes to the scientific community. This policy applies to NIH intramural research as well as extramural research funded by grants, and cooperative agreements, and contracts.

Investigators who have such resources are encouraged to consult the appropriate PHS program administrators who may be of assistance

Reprinted from NIH Guide for Contracts and Grants 17(29):1, September 16, 1988.

Suggested Citation:"Part C: Specific Research Policies and Practices." National Academy of Sciences, National Academy of Engineering, and Institute of Medicine. 1993. Responsible Science: Ensuring the Integrity of the Research Process: Volume II. Washington, DC: The National Academies Press. doi: 10.17226/2091.
×

in determining a suitable distribution mechanism. For research and development contracts, approval should be obtained from the NIH Contracting Officer before distribution of unique resources, unless the terms of the contract permit distribution without prior clearance of the Contracting Officer. In order to facilitate the availability of unique or novel biological materials and resources developed with PHS funds, investigators may distribute the materials through their own laboratory or institution or submit them, if appropriate, to entities such as the American Type Culture Collection or similar repositories. In the case of unique biological information such as DNA sequences or crystallographic coordinates, investigators are expected to submit them to the appropriate data banks because they otherwise are not truly accessible to the scientific community. When distributing unique resources, investigators are encouraged to include pertinent information on the nature, or quality, or characterization of the materials.

Investigators must exercise great care to ensure that resources do not identify original donors or subjects, directly or through identifiers, such as codes linked to the donors or subjects.

B. Distribution Costs

Institutions and investigators may charge the requester, if necessary, for the reasonable cost of production of unique biological materials, and for packaging and shipping. Such costs may include personnel, supplies, and other directly related expenses. It should be noted, however, that such a charge accrues as general program income. This should not be an impediment to the distribution of materials, but investigators and institutions are advised that:

  1. for grants, the income is governed by 45 CFR Part 74 and it must be reported on the Financial Status Report. Questions regarding these policies and the treatment of income should be directed to the Grants Management Officer.

  2. for contracts, the income is governed by Federal Acquisition Regulations (FAR) 45.610-3. Contracting Officers must be contacted before generating any revenues from the distribution of materials. Any contract under which research resources would be sold requires specific contract instructions. Existing contracts may require an amendment and specific approval of the Contracting Officer to render them allowable.

Suggested Citation:"Part C: Specific Research Policies and Practices." National Academy of Sciences, National Academy of Engineering, and Institute of Medicine. 1993. Responsible Science: Ensuring the Integrity of the Research Process: Volume II. Washington, DC: The National Academies Press. doi: 10.17226/2091.
×

C. Inventions and Commercialization

This policy does not discourage, impede, or prohibit the organization that develops unique biologic materials or intellectual property from commercializing the materials or licensing them for commercial purposes. Investigators may make their materials available to others with appropriate restrictions and licensing terms as they and their institutions deem necessary.

Institutions are reminded that some of these products may be inventions subject to the various laws and regulations applicable to patents and need to be reported. When reporting is required, it should occur at the earliest possible time. (See P.L. 96-517, P.L. 98-620, and 37 CFR 401.)

Suggested Citation:"Part C: Specific Research Policies and Practices." National Academy of Sciences, National Academy of Engineering, and Institute of Medicine. 1993. Responsible Science: Ensuring the Integrity of the Research Process: Volume II. Washington, DC: The National Academies Press. doi: 10.17226/2091.
×
Page 223
Suggested Citation:"Part C: Specific Research Policies and Practices." National Academy of Sciences, National Academy of Engineering, and Institute of Medicine. 1993. Responsible Science: Ensuring the Integrity of the Research Process: Volume II. Washington, DC: The National Academies Press. doi: 10.17226/2091.
×
Page 224
Suggested Citation:"Part C: Specific Research Policies and Practices." National Academy of Sciences, National Academy of Engineering, and Institute of Medicine. 1993. Responsible Science: Ensuring the Integrity of the Research Process: Volume II. Washington, DC: The National Academies Press. doi: 10.17226/2091.
×
Page 225
Next: 12 Policy for Recording and Preserving Scientific Data »
Responsible Science: Ensuring the Integrity of the Research Process: Volume II Get This Book
×
Buy Paperback | $75.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Volume II of Responsible Science includes background papers and selected institutional reports, policies, and procedures that were used to develop Volume I. Topics discussed include traditions of mentorship in science; data handling practices in the biological sciences; academic policies and standards governing the conduct of research practices; congressional interest in issues of misconduct and integrity in science; the regulatory experience of human subjects research; and the roles of scientific and engineering societies in fostering research integrity.

The panel also considers numerous institutional policy statements adopted by research universities and professional societies that address different aspects of misconduct or integrity in science. These statements have been selected to convey the diverse approaches for addressing such matters within research institutions.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!